Stake Announced Sponsor buyer
Apollo stake in newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business
€3bn consideration
Announced 10 Jul 2026
Advisers
newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business
Target
Not disclosed
Apollo
Acquirer
- Legal adviser
- Target
- newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business
- Acquirer
- Apollo
- Seller
- Bayer
- Buyer based in
- United States
- Seller based in
- Germany
- Structure
- Minority stake
- Sector
- Pharma
- Tags
- Pharma, Healthcare
In the league tables
Similar deals
- WaveRise Investments acquisition of Novartis India Mar 2026 · Pharma
- Quadria Capital-led consortium acquisition of Apex Healthcare Berhad Feb 2026 · Pharma
- Polomar Health Services and Altanine merger Jul 2025 · Healthcare
- Covetrus and MWI Animal Health merger Feb 2026 · US$3.5bn · Animal Health
- Angelini Pharma S.p.A. acquisition of Catalyst Pharmaceuticals May 2026 · US$4.1bn · Pharma
Sources
- Jul 2026 Latham Watkins Advises Apollo on Investment in Bayer Long Acting Reversible Contraceptives Business lw.com
- 10 Jul 2026 Apollo to Invest in Bayer Unit paulweiss.com

